You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 16, 2024

Akorn Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for AKORN, and what generic and branded alternatives to AKORN drugs are available?

AKORN has twenty-six approved drugs.

There are two tentative approvals on AKORN drugs.

Drugs and US Patents for Akorn

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Akorn ACETAMINOPHEN AND CODEINE PHOSPHATE acetaminophen; codeine phosphate SOLUTION;ORAL 040119-001 Apr 26, 1996 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
Akorn DICLOFENAC SODIUM diclofenac sodium SOLUTION/DROPS;OPHTHALMIC 077845-001 Apr 17, 2008 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
Akorn NEMBUTAL pentobarbital sodium SUPPOSITORY;RECTAL 083247-004 Jan 25, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
Akorn DIPHENHYDRAMINE HYDROCHLORIDE diphenhydramine hydrochloride SYRUP;ORAL 072416-001 Sep 28, 1990 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.